Search
Dianthus Therapeutics Inc
DNTHAdd to Watchlist
106.920USD
-5.720-5.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.84BMarket Cap
LossP/E TTM
Dianthus Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Dianthus Therapeutics Inc is 8.88, ranking 43 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -25.28, which is -116.40% below the recent high of 4.15 and -33.15% above the recent low of -33.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.